Kliniczny Szpital Wojewodzki Nr 2 Im. Sw. Jadwigi Krolowej W Rzeszowie — Clinical Trial Site

26 Registered trials

8 Currently recruiting

Organisation

Kliniczny Szpital Wojewodzki Nr 2 Im. Sw. Jadwigi Krolowej W Rzeszowie

Location

Rzeszow, Poland

Identifier

ORG-100037272

Address

Ul. Lwowska 60, 35-301, Poland

Departments

#3207 - Klinika Reumatologii
Clinic of Pediatric Onco-Hematology
Endocrinology and Child Diabetology
I Klinika Pediatrii i Gastroenterologii Dzieciece] z Pododdzialem Kardiologii Dzieciecej
I Klinika Pediatrii i Gastroenterologii Dziecięcej z Pododdziałem Kardiologii Dziecięcej
II Klinika Pediatrii, Endokrynologii i Diabetologii Dziecięcej
Klinika Ch. Wewnętrznych, Nefrologii i Endokrynologii z Prac. Med. Nuklearnej i Ośr. Dializoterapii
Klinika Kardiologii z Pododdziałem Ostrych Zespołów Wieńcowych
Klinika Neurologii Dziecięcej i Pediatrii
Klinika Neurologii z Pododdziałem Leczenia Udarów Mózgu
Klinika Noworodków z Pododdziałem Intensywnej Terapii Noworodka
Klinika Onkohematologii Dzieciecej
Klinika Reumatologii
N/A
NA

Clinical trials at this site (26)

Search interface

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr… Not authorised

2025-523820-26-00 Growth Hormone Deficiency (GHD) 5
A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending

2023-509176-42-00 Obesity and T2D 11
An Open label, Single Arm, Single dose Study in Pediatric Participants aged ≥2 to <12 years with a Suspected or Confirmed Bacterial Infecti… Pending

2025-522916-17-00 Urinary Tract Infections 3
Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS) Recruiting

2025-522257-19-00 Relapsing Multiple Sclerosis 10 2026-05-12
A study to evaluate the safety, tolerability, and pharmacokinetics of VABOMERE (meropenem-vaborbactam) in children with complicated urinary … Recruiting

2024-516360-29-00 Complicated Urinary Tract Infection (cUTI), Acute Pyel 4 2025-04-25
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Idiopathic steroid-sensitive nephrotic syndrome 5 2025-04-28
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Acute lymphoblastic leukemia 10 2024-11-18
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
A multicentre study evaluating the safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtP… Recruiting

2024-518509-17-00 Acute ischemic stroke 4 2022-01-10
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
A research study comparing how well different doses of the medicine NNC0519-0130 can reduce kidney damage in people living with chronic kidn… Ended

2024-510846-15-00 Chronic Kidney Disease, with or without Type 2 diabetes 4 2025-04-14
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended

2023-508055-40-00 Obesity 6 2025-02-18
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A research study looking at how safe somapacitan is and how well it works in children who need help to grow – REAL 9 Ended

2022-501055-87-01 Noonan syndrome 5 2023-05-18
Phase 3 study to evaluate two regimens of ianalumab on top of standardof- care therapy in patients with systemic lupus erythematosus (SIRIUS… Ended

2023-508498-97-00 Systemic Lupus Erythematosus 5 2023-02-03
A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow Ended

2023-506927-27-00 Children with short stature either born small for gesta 5 2022-08-29
Phase 3 Study of Anifrolumab in Adult Patients with Active Proliferative Lupus Nephritis Ended

2023-506359-68-00 Active Proliferative Lupus Nephritis 5 2022-04-08
Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia Ended

2023-509170-33-00 Classic Congenital Adrenal Hyperplasia (CAH) 5 2021-11-23
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Acute lymphoblastic leukemia 5 2021-07-01
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02
Corticotrophin Releasing Factor 2 Agonist For the Treatment of Worsening Heart Failure (WHF) – The CRAFT-WHF Study Halted

2024-518951-52-00 Worsening Heart Failure 4 2025-11-12
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) Ended

2024-517612-29-00 acute heart failure 11 2023-02-14